Cannabis Improves Obsessive-Compulsive Disorder—Case Report and Review of the Literature

Frontiers in Psychiatry

Kirsten R. Müller-Vahl²  Natalia Szejko³  Carolin Fremer⁴ 

[1] Emergency Neurology, Department of Neurology, Yale School of Medicine, New Haven, CT, United States;Clinic of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany;Department of Bioethics, Medical University of Warsaw, Warsaw, Poland;Department of Neurology, Medical University of Warsaw, Warsaw, Poland;;Division of Neurocritical Care &

关键词: obsessive-compulsive disorder;    OCD;    cannabinoids;    cannabis-based medicine;    endocannabinoid system;    cannabis;   

DOI  :  10.3389/fpsyt.2020.00681

来源: DOAJ

【 摘 要 】

Although several lines of evidence support the hypothesis of a dysregulation of serotoninergic neurotransmission in the pathophysiology of obsessive-compulsive disorder (OCD), there is also evidence for an involvement of other pathways such as the GABAergic, glutamatergic, and dopaminergic systems. Only recently, data obtained from a small number of animal studies alternatively suggested an involvement of the endocannabinoid system in the pathophysiology of OCD reporting beneficial effects in OCD-like behavior after use of substances that stimulate the endocannabinoid system. In humans, until today, only two case reports are available reporting successful treatment with dronabinol (tetrahydrocannabinol, THC), an agonist at central cannabinoid CB1 receptors, in patients with otherwise treatment refractory OCD. In addition, data obtained from a small open uncontrolled trial using the THC analogue nabilone suggest that the combination of nabilone plus exposure-based psychotherapy is more effective than each treatment alone. These reports are in line with data from a limited number of case studies and small controlled trials in patients with Tourette syndrome (TS), a chronic motor and vocal tic disorder often associated with comorbid obsessive compulsive behavior (OCB), reporting not only an improvement of tics, but also of comorbid OCB after use of different kinds of cannabis-based medicines including THC, cannabis extracts, and flowers. Here we present the case of a 22-year-old male patient, who suffered from severe OCD since childhood and significantly improved after treatment with medicinal cannabis with markedly reduced OCD and depression resulting in a considerable improvement of quality of life. In addition, we give a review of current literature on the effects of cannabinoids in animal models and patients with OCD and suggest a cannabinoid hypothesis of OCD.

【 授权许可】

Unknown